Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signalling

Nephron - Experimental Nephrology

Volumn 120, Issue 4, 2012, Pages

  Huang, L L ^a,b   Nikolic Paterson, D J ^a,b   Ma, F Y ^a,b   Tesch, G H ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aldosterone; Fibroblast; Growth factors; Kidney; Proliferation; Signal transduction

Indexed keywords

ALDOSTERONE; ALPHA TUBULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPLERENONE; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PROTEIN MEKK7; RAC PROTEIN; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; GROWTH FACTOR RECEPTOR; MINERALOCORTICOID ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INDUCTION; FIBROBLAST; KIDNEY FIBROBLAST; KIDNEY FIBROSIS; KIDNEY INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; URETER OBSTRUCTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; KIDNEY; METABOLISM; PHYSIOLOGY;

ALDOSTERONE; ANIMALS; CELL LINE; CELL PROLIFERATION; FIBROBLASTS; KIDNEY; MAP KINASE SIGNALING SYSTEM; MICE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RECEPTORS, GROWTH FACTOR; RECEPTORS, MINERALOCORTICOID;

EID: 84869861374     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000339500     Document Type: Article

References (26)

1. Hostetter TH, Ibrahim HN: ALDOSTERONE in chronic kidney and cardiac disease. J Am Soc Nephrol 2003; 14: 2395-2401. (Pubitemid 37052388)
2. Kang YS, Ko GJ, Lee MH, Song HK, Han SY, Han KH, Kim HK, Han JY, Cha DR: EFFECT of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats. Nephrol Dial Transplant 2009; 24: 73-84.
3. Miana M, de Las Heras N, Rodriguez C, Sanz-Rosa D, Martin-Fernandez B, Mezzano S, Lahera V, Martinez-Gonzalez J, Cachofeiro V: EFFECT of eplerenone on hypertension-Associated renal damage in rats: Potential role of peroxisome proliferator activated receptor gamma (PPAR-gamma). J Physiol Pharmacol 2011; 62: 87-94.
4. Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK: MINERALOCORTICOID receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology 2006; 147: 5363-5373. (Pubitemid 44790591)
5. Huang W, Xu C, Kahng KW, Noble NA, Border WA, Huang Y: ALDOSTERONE and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells. Am J Physiol Renal Physiol 2008; 294:F1287-F1295.
6. Yamahara H, Kishimoto N, Nakata M, Okazaki A, Kimura T, Sonomura K, Matsuoka E, Shiotsu Y, Adachi T, Matsubara H, Iwasaka T, Mori Y: DIRECT aldosterone action as a profibrotic factor via ROS-mediated SGK1 in peritoneal fibroblasts. Kidney Blood Press Res 2009; 32: 185-193.
7. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A: ALDOSTERONE stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 2005; 46: 1039-1045.
8. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM: MYOFIBROBLASTS and the progression of diabetic nephropathy. Nephrol Dial Transplant 1997; 12: 43-50. (Pubitemid 27046200)
9. Zhang A, Jia Z, Guo X, Yang T: ALDOSTERONE induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 2007; 293:F723-F731. (Pubitemid 47403342)
10. Hughes J, Brown P, Shankland SJ: CYCLIN kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol 1999; 277:F948-F956. (Pubitemid 30046070)
11. Stockand JD, Meszaros JG: ALDOSTERONE stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol 2003; 284:H176-H184. (Pubitemid 36076284)
12. Neumann S, Huse K, Semrau R, Diegeler A, Gebhardt R, Buniatian GH, Scholz GH: ALDOSTERONE and D -glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension 2002; 39: 756-760. (Pubitemid 34252870)
13. Irita J, Okura T, Kurata M, Miyoshi K-I, Fukuoka T, Higaki J: OSTEOPONTIN in rat renal fibroblasts: Functional properties and transcriptional regulation by aldosterone. Hypertension 2008; 51: 507-513. (Pubitemid 351156440)
14. Hewitson TD, Martic M, Darby IA, Kelynack KJ, Bisucci T, Tait MG, Becker GJ: INTRACELLULAR cyclic nucleotide analogues inhibit in vitro mitogenesis and activation of fibroblasts derived from obstructed rat kidneys. Nephron Exp Nephrol 2004; 96:e59-e66.
15. Lim AK, Ma FY, Nikolic-Paterson DJ, Thomas MC, Hurst LA, Tesch GH: ANTIBODY blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia 2009; 52: 1669-1679.
16. Xue C, Siragy HM: LOCAL renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 2005; 46: 584-590. (Pubitemid 41379384)
17. Gekle M, Freudinger R, Mildenberger S, Silbernagl S: RAPID actions of aldosterone on cells from renal epithelium: The possible role of EGF-Receptor signaling. Steroids 2002; 67: 499-504. (Pubitemid 34311766)
18. Huang S, Zhang A, Ding G, Chen R: ALDOSTERONE-Induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am J Physiol Renal Physiol 2009; 296:F1323-F1333.
19. Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC: RECEPTOR heterodimerization: Essential mechanism for platelet-Derived growth factor-Induced epidermal growth factor receptor transactivation. Mol Cell Biol 2001; 21: 6387-6394. (Pubitemid 32927407)
20. Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM: ALDOSTERONE and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-Regulated redoxsensitive RhoA pathways. Arterioscler Thromb Vasc Biol 2008; 28: 1511-1518.
21. Milenkovic I, Weick M, Wiedemann P, Reichenbach A, Bringmann A: p2y receptormediated stimulation of Müller glial cell DNA synthesis: Dependence on EGF and PDGF receptor transactivation. Invest Ophthalmol Vis Sci 2003; 44: 1211-1220. (Pubitemid 36297842)
22. Kawano H, Kim S, Ohta K, Nakao T, Miyazaki H, Nakatani T, Iwao H: DIFFERENTIAL contribution of three mitogen-Activated protein kinases to PDGF-BB-Induced mesangial cell proliferation and gene expression. J Am Soc Nephrol 2003; 14: 584-592. (Pubitemid 36246001)
23. Gao Z, Sasaoka T, Fujimori T, Oya T, Ishii Y, Sabit H, Kawaguchi M, Kurotaki Y, Naito M, Wada T, Ishizawa S, Kobayashi M, Nabeshima Y, Sasahara M: DELETION of the PDGFRbeta gene affects key fibroblast functions important for wound healing. J Biol Chem 2005; 280: 9375-9389. (Pubitemid 40409631)
24. Wang S, Wilkes MC, Leof EB, Hirschberg R: IMATINIB mesylate blocks a non-Smad TGFbeta pathway and reduces renal fibrogenesis in vivo. FASEB J 2005; 19: 1-11. (Pubitemid 40069914)
25. Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, Muller G: tgf-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 2001; 59: 579-592. (Pubitemid 32157922)
26. Zitt E, Eller K, Huber JM, Kirsch AH, Tagwerker A, Mayer G, Rosenkranz AR: THE selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomerulonephritis. Int J Clin Exp Pathol 2011; 4: 606-615.